Sareum Holdings plc (AIM:SAR)
London · Delayed Price · Currency is GBP · Price in GBX 15.50
-4.40 (-22.11%)
Oct 10, 2025, 5:15 PM GMT+1
Sareum Holdings Market Cap
Sareum Holdings has a market cap or net worth of 21.40 million as of October 10, 2025. Its market cap has decreased by -25.19% in one year.
Market Cap
21.40M
Enterprise Value
17.26M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
15.50
Market Cap Chart
Since December 6, 2004, Sareum Holdings's market cap has increased from 8.69M to 21.40M, an increase of 146.16%. That is a compound annual growth rate of 4.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 21.40M | -30.08% |
| Dec 31, 2024 | 30.61M | -26.79% |
| Dec 29, 2023 | 41.81M | -25.56% |
| Dec 30, 2022 | 56.16M | -66.33% |
| Dec 31, 2021 | 166.77M | 110.46% |
| Dec 31, 2020 | 79.24M | 626.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 200.66B |
| GSK plc | 65.98B |
| Haleon | 30.29B |
| Smith & Nephew | 11.51B |
| ConvaTec Group | 4.86B |
| Hikma Pharmaceuticals | 4.10B |
| HUTCHMED (China) | 1.99B |
| Genus | 1.75B |